au.\*:("MEHLING, M")
Results 1 to 5 of 5
Selection :
FURTHER VALIDATION OF THE GREAT ATLANTIC AND PACIFIC SIGHT WORD LISTOTTO W; CHESTER R; MEHLING M et al.JOURNAL OF EDUCATIONAL RESEARCH. 1974, Vol 67, Num 8, pp 363-365Article
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosisMEHLING, M; JOHNSON, T. A; ANTEL, J et al.Neurology. 2011, Vol 76, Num 8, issn 0028-3878, S20-S27, SUP3Article
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisMEHLING, M; BRINKMANN, V; ANTEL, J et al.Neurology. 2008, Vol 71, Num 16, pp 1261-1267, issn 0028-3878, 7 p.Article
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody developmentHEGEN, H; MILLONIG, A; MALUCCHI, S et al.Multiple sclerosis. 2014, Vol 20, Num 5, pp 577-587, issn 1352-4585, 11 p.Article
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosisKUHLE, J; LEPPERT, D; PETZOLD, A et al.Neurology. 2011, Vol 76, Num 14, pp 1206-1213, issn 0028-3878, 8 p.Article